Cancer Drug Current Events | Cancer Drug News
|
| Page
1 of
140 |
2789 Results |
|
|
|
Sort By:
Page Views | Date |
Harnessing Microbes to Kill Cancer
An ingenious new way to attack cancer tumours is being developed by medical researchers from Nottingham as part of an EU consortium, the Society for General Microbiology's Spring Meeting in Edinburgh heard today, Tuesday 8 April 2003. The problem with powerful anti-cancer drugs is that they kill healthy cells too, and concentrations needed to wipe... view more... (2003-04-02)
Burnham Researchers Turn Cancer Friend into Cancer Foe
Burnham Institute for Medical Research today announced that scientists have created a peptide that binds to Bcl-2, a protein that protects cancer cells from programmed cell death, and converts it into a cancer cell killer. view more (2008-10-08)
New Chemo Cocktail Blocks Breast Cancer Like a Fence
Think of a protective fence that blocks the neighbor's dog from charging into your backyard. The body, too, has fences -- physical and biochemical barriers that keep cells in their place. view more (2009-10-07)
Breast cancer drug receives FDA approval
A new use for the breast cancer drug Herceptin was approved by the FDA yesterday, a move that means more treatment options for the 25 percent of breast cancer patients with early-stage HER-2 positive breast cancer. view more (2006-11-20)
Pazopanib shrinks lung cancers before surgery
Pazopanib, a new oral angiogenesis inhibitor, has demonstrated interesting activity in difficult to treat non-small-cell lung cancer, US researchers report. view more (2008-09-17)
PSA test has higher accuracy for patients taking finasteride
Finasteride is a drug prescribed for men whose prostates have become enlarged. The drug decreases prostate swelling and helps men with urinary problems. view more (2006-08-16)
Potential prostate cancer treatment improvements discovered by researchers at Cedars-Sinai
In a study to be published in the April, 2006 issue of the British Journal of Urology International, researchers at Cedars-Sinai Medical Center have shown that Raloxifene, a drug commonly used to treat osteoporosis, has a potential clinical benefit in treating men with prostate cancer. view more (2006-03-22)
Inhibiting cell process may give cancer drug a boost
A molecule that interferes with the internal scaffolding that shapes the cell may kill cancer cells, retard the growth of tumors and give a boost to a common chemotherapy drug. view more (2006-05-04)
Study reveals mechanism for cancer-drug resistance
Using the worm Caenorhabditis elegans, researchers at UT Southwestern Medical Center have discovered a mechanism by which cancer cells become resistant to a specific class of drugs. view more (2006-10-10)
UC Davis researchers discover genetic switch involved in cells' response to radiation therapy
UC Davis Cancer Center researchers have discovered a genetic switch that causes cancer cells to become more sensitive to a drug administered to enhance radiation therapy effectiveness. view more (2005-11-17)
Chemotherapy appears to delay cancer recurrence following surgery for pancreatic cancer
Use of the drug gemcitabine for chemotherapy significantly delays the recurrence of cancer, compared to no chemotherapy, for patients following pancreatic cancer surgery. view more (2007-01-17)
Potential dangers of long term tamoxifen use
Tamoxifen prolongs the life of women with breast cancer and may significantly reduce the risk of developing the disease in those with an inherited tendency. But, suggests a leading article in the Journal of Clinical Pathology, long term use may produce other serious abnormalities, including cancer. view more (1999-02-12)
Can cancer drugs combine forces?
Individuals with chronic myeloid leukemia (CML) are treated first with a drug known as imatinib (Gleevec), which targets the protein known to cause the cancer (BCR-ABL). view more (2007-08-17)
Study shows chemotherapy improves survival among older breast cancer patients
The average age of a woman diagnosed with breast cancer is 63, so it is critical to have effective proven, therapies for an older patient population. view more (2009-05-14)
Drug compound leads to death of ovarian cancer cells resistant to chemotherapy
In a discovery that may be useful for maintaining remission in chemo-resistant ovarian cancer, Yale scientists report that pre-clinical studies have shown the drug compound NV-128 can induce the death of ovarian cancer cells by halting the activation of a protein pathway called mTOR. view more (2008-04-18)
UAB Study Shows Drug May Fight Biliary Cancers
Laboratory studies by University of Alabama at Birmingham (UAB) researchers have shown that the drug triphendiol (NV-196) causes cell death in pancreatic and bile duct cancer cell lines, slows tumor growth and sensitizes tumors to chemotherapy treatments. view more (2008-04-16)
Discovery about obesity drug helping scientists develop new cancer treatments
Based on their surprising discovery that an obesity drug can kill cancer cells, scientists at Wake Forest University School of Medicine have made a new finding about the drug's effects and are working to design more potent cancer treatments. view more (2007-07-09)
A new pharmaceutical drug that halts progress of metastatic kidney cancer
Research has shown the efficacy of a pharmaceutical drug known as sunitinib which halts progress of metastatic kidney cancer. view more (2007-03-02)
OHSU Cancer Institute researchers find novel chemo drug helps treat prostate cancer
Men with a certain type of prostate cancer have been shown to respond to a new chemotherapy drug, Sagopilone, plus prednisone in an international trial led by Oregon Health & Science University Cancer Institute researchers. view more (2008-06-02)
Study reveals mechanism for cancer-drug resistance
Using the worm Caenorhabditis elegans, researchers at UT Southwestern Medical Center have discovered a mechanism by which cancer cells become resistant to a specific class of drugs. view more (2006-10-11)
|
|
| Page
1 of
140 |
2789 Results |
|
|
|
Sort By:
Page Views | Date |
|
